Alzheimer's Drug Cited As Medicare Premium Jumps By USD 21.60
Alzheimer's Drug Cited As Medicare Premium Jumps By USD 21.60
Washington (AP) Medicare's Part B outpatient premium will jump by USD 21.60 next year, one of the largest increases ever. Officials said Friday a new Alzheimer's drug is responsible for about half of that. The increase guarantees that health care costs will gobble up a big chunk of the recently announced Social Security cost-of-living allowance, a boost that had worked out to USD 92 a month for the average retired worker..

Washington (AP) Medicare’s Part B outpatient premium will jump by USD 21.60 next year, one of the largest increases ever. Officials said Friday a new Alzheimer’s drug is responsible for about half of that. The increase guarantees that health care costs will gobble up a big chunk of the recently announced Social Security cost-of-living allowance, a boost that had worked out to USD 92 a month for the average retired worker.

Medicare officials told reporters on Friday that about half the increase is attributable to contingency planning if the program has to cover Aduhelm, a new USD 56,000-a-year medication for Alzheimer’s disease. The drug would add to program costs because it’s administered in a doctor’s office and paid for under Medicare’s outpatient benefit. The announcement on premiums comes as Congress is considering Democratic legislation that would curb what Medicare pays for medications. The new Part B premium will be USD 170.10 a month. (AP) .

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Read all the Latest Politics News here

What's your reaction?

Comments

https://filka.info/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!